Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-490 is a non-coding RNA molecule, classified as a microRNA, which regulates gene expression post-transcriptionally by promoting mRNA degradation or inhibiting translation[3]. It is processed into two mature forms, microRNA-490-3p and microRNA-490-5p, each with distinct biological roles and target gene sets[1]. miR-490 is located in the intron of the cholinergic receptor muscarinic 2 (CHRM2) gene on chromosome 7q33[1]. Both miR-490-3p and miR-490-5p have been implicated in suppressing tumor cell proliferation, migration, invasiveness, and in modulating epithelial-mesenchymal transition across a variety of cancers, including colorectal, gastric, hepatocellular, bladder, and more[1][2]. These microRNAs exert their effects by targeting genes such as cyclin D1 (CCND1), TGFβ receptor 1 (TGFβR1), BUB1, PIK3CA, and many others, impacting crucial signaling pathways (notably TGF-β, Wnt/β-catenin, MAPK, and PI3K/Akt)[1]. miR-490-3p, in particular, has been linked to the regulation of the cell cycle (notably silencing CDK1 and inducing G1/S arrest), reduced cancer cell proliferation, and sensitization or resistance to chemotherapeutic drugs such as cisplatin and paclitaxel[2]. Both forms serve as promising biomarkers for cancer diagnosis and prognosis, though further work is required to translate these findings into targeted therapies[1].
Modulation of gene expression via RNA-induced silencing complex (RISC); suppression of gene translation; promotion of mRNA degradation; interference with cell cycle regulators such as CDK1 and signaling pathways (e.g., TGF-β, MAPK, PI3K/Akt)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-490 (miR-490).